The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
No information on job gains number available
Announcement Date
27 October 2020
Employment effect (start)
27 October 2020
Foreseen end date
Description
The Norwegian company Benzoak Vet, owned by ACD Pharma, has shifted the production of its sedative and anesthetic from Belgium to Norway in 2020. The previous manufacturer was VWR in Belgium, and the new producer is Pharma Production in Oslo. This strategic move is in line with the increased focus on domestic pharmaceutical production in Norway, following the COVID-19 pandemic. The decision was motivated by the company desire for proximity and simplified production management. The transition also involves modernizing the product's composition to comply with updated regulations, with no impact on its clinical properties.
Eurofound (2020), Benzoak Vet, Reshoring in Norway, factsheet number 292, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/292.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
